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The quest to determine how precise neural activity patterns mediate computation, behavior, and pathology would be greatly
aided by a set of tools for reliably activating and inactivating genetically targeted neurons, in a temporally precise and rapidly
reversible fashion. Having earlier adapted a light-activated cation channel, channelrhodopsin-2 (ChR2), for allowing neurons to
be stimulated by blue light, we searched for a complementary tool that would enable optical neuronal inhibition, driven by
light of a second color. Here we report that targeting the codon-optimized form of the light-driven chloride pump
halorhodopsin from the archaebacterium Natronomas pharaonis (hereafter abbreviated Halo) to genetically-specified neurons
enables them to be silenced reliably, and reversibly, by millisecond-timescale pulses of yellow light. We show that trains of
yellow and blue light pulses can drive high-fidelity sequences of hyperpolarizations and depolarizations in neurons
simultaneously expressing yellow light-driven Halo and blue light-driven ChR2, allowing for the first time manipulations of
neural synchrony without perturbation of other parameters such as spiking rates. The Halo/ChR2 system thus constitutes
a powerful toolbox for multichannel photoinhibition and photostimulation of virally or transgenically targeted neural circuits
without need for exogenous chemicals, enabling systematic analysis and engineering of the brain, and quantitative
bioengineering of excitable cells.
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Resolution. PLoS ONE 2(3): e299. doi:10.1371/journal.pone.0000299
INTRODUCTION
Much effort in neuroscience is directed towards determining how
neural activity in a specific set of neurons contributes to a particular
neural computation, behavior, or pathological state. Over the last
hundred years, thousands of studies have investigated the neural
substrates necessary and sufficient for sensation, perception,
cognition, and action, via pharmacological or ablative neural
silencing (or studies of human patients with localized lesions), or
localized electrical microstimulation of specified neural circuits
(e.g., [1–11]). Technologies for targeted neural silencing or
stimulation have also found clinical uses for treatment of many
neurological and psychiatric disorders including Parkinson’s
disease, cluster headache, drug-resistant depression, and a variety
of other hard-to-treat disorders (e.g., [12–17]). The use of neural
control technologies in these two complementary quests–the
analysis, and engineering, of the brain–would be greatly aided
by a tool for reliably activating and inactivating genetically-
targeted neurons in a temporally-precise and rapidly-reversible
fashion. A toolbox for bi-directionally sculpting activity in targeted
cell types at the millisecond timescale could greatly help answer
a number of outstanding classical questions in neuroscience, and
enable completely new and previously-intractable vistas to be
explored: What are the precise brain regions, cell types, and neural
activity patterns required at each phase–sensory, decision-making,
motor–of a specific behavior? To mediate a particular perception,
feeling, decision, memory, or action, what is the precise number of
neurons that must be active within a certain region, and when and
how long must they be active? What is the causal role of neural
synchrony and precise spike timing in neural computation,
plasticity, and circuit pathology? As memories are encoded,
consolidated, actively reversed, and forgotten, how do the critical
neural loci of memory change? How can we exert control over the
neural circuits left in disarray by a myriad of neurological and
psychiatric diseases, and correct the activity patterns so as to
restore normal brain function?
Having previously adapted a light-activated cation channel
from green algae, channelrhodopsin-2 (ChR2), for sensitizing
targeted neurons to temporally-precise excitation by pulses of blue
light [18], we searched for a complementary optical tool that
would enable simultaneously-and independently-controllable neu-
ronal inhibition, driven by light of a second color. In recent years,
a diversity of methods have been proposed for reversibly
inactivating neurons [19–26]; the majority of these methods rely
upon chemical delivery and washout to temporally delimit the
duration of inactivation, which accordingly limits the induction
and reversal kinetics to periods of at least several minutes or hours.
One tantalizing study has shown that expressing the rat protein
rhodopsin 4 (RO4) in neurons can enable light-driven G-protein-
mediated neural inhibition [27]. Perhaps due to the multiple-
component G-protein signaling pathway involved, induction of
inhibition was partial, and proceeded with a time constant of
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PLoS ONE | www.plosone.org 1 March 2007 | Issue 3 | e299,300 ms, with release from inhibition proceeding with a time
constant of ,6 seconds after light shutoff. In contrast, optical
activation via ChR2 offers neural excitation with temporal
resolution on the order of 1 millisecond; the ability to optically
silence neurons on the same timescale, and especially to exert
bidirectional control of membrane voltage with two colors of light,
would clearly be of enormous benefit both as a basic science tool
and as a novel bioengineering building-block.
We screened single-component, type I microbial opsins with
significant homology to ChR2, which has been shown to possess
these important properties in the context of optical activation of
mammalian neurons [18,28,29]. Specifically, we surveyed the class
of archaebacterial light-activated chloride pumps called halorho-
dopsins [30–33], which are seven-transmembrane proteins
capable of driving inward chloride currents in response to green-
yellow light (525–650 nm). The archaebacteria that express
halorhodopsins typically live in environments with very high
chloride concentrations (e.g., 1–5 M), and use halorhodopsin to
pump chloride into the cell (even against the membrane potential)
in order to maintain osmotic balance and accordingly reduce
energy expenditure. Some wild-type halorhodopsins have been
shown to preserve functionality at much lower chloride concen-
trations, comparable to those found in mammalian cerebrospinal
fluid [30,34]. Here we report that targeting the mammalian
codon-optimized form of halorhodopsin from the archaebacterium
Natronomas pharaonis (hereafter abbreviated Halo) to genetically-
specified neuron subtypes enables them to be silenced reliably and
reversibly by millisecond-timescale pulses of yellow light. We
demonstrate that rapidly-alternating pulses of yellow and blue light
can drive high-fidelity, naturalistic trains of neural hyperpolariza-
tions and depolarizations in neurons simultaneously expressing
yellow light-driven Halo and blue light-driven ChR2, enabling for
the first time experiments that perturb neural synchrony without
alteration of spike rate. In all of these experiments, no chemical
supplementation was needed to enable Halo or ChR2 function in
mammalian neurons. Thus, the ChR2/Halo system constitutes
a powerful toolbox enabling multichannel photoinhibition and
photostimulation of virally-or transgenically-targeted neural circuits,
enabling thesystematicanalysisandengineeringof neuralcircuits,as
well as the quantitative bioengineering of excitable cells.
RESULTS
We first created a fusion protein comprising the mammalian
codon-optimized form of N. pharaonis halorhodopsin (Halo), with
EGFP added in-frame at the C-terminus for ease of visualization
(see Methods for details). When expressed in cultured hippocam-
pal neurons using the CaMKII promoter, which targets excitatory
neurons of the forebrain [35], Halo-EGFP fluoresced brightly, and
appeared evenly distributed around the neuron (Fig. 1A). When
exposed to ,10 mW/mm
2 yellow light (from a xenon lamp,
filtered by a standard Texas red excitation filter from Chroma,
bandpass 560627.5 nm), voltage-clamped hippocampal neurons
expressing Halo experienced outward currents with rapid onset,
stable steady-state amplitude, and abrupt shut-off after cessation of
illumination. No supplementation of culture or recording media
with the essential halorhodopsin cofactor all-trans retinal was
necessary for strong currents to be elicited, consistent with prior
work that demonstrated high enough levels of all-trans retinal in
mammalian culture and brain to enable type I opsin functionality
[18,28]. Light pulses elicited pulse amplitudes of 88.7632.8 pA
(mean6st. dev.; n=22 neurons; Fig. 1B). Repeating a 1-second
pulse of yellow light twice, spaced by 1 second of darkness,
resulted in similar pulse amplitudes each time (p.0.50, paired t-
test), although during each light pulse, a slight perceptible decay
was visible (analyzed later in the manuscript). This relatively stable
current amplitude is consistent with what is known about the
halorhodopsin photocycle, which can fully complete within tens
of milliseconds [33]. The light-elicited current amplitude did not
vary significantly with holding voltage when assayed at-70 mV,
230 mV, and+10 mV (F=0.004, p.0.95, ANOVA with factor of
holding voltage), nor did any measured kinetic parameters vary
across this voltage range, such as onset or offset times of current
pulses (F,0.6, p.0.55 for all comparisons, ANOVA; Fig. 1C).
The onset and offset times of elicited currents were strikingly rapid,
,10–15 ms at all holding voltages tested (Fig. 1Ci, 1Cii). When
held in current clamp, hippocampal neurons underwent peak
hyperpolarizations of 32.9614.4 mV (n=19 neurons) in response
to pulses of yellow light, with no difference between the peak
hyperpolarizations achieved by two 1-second pulses separated by
a 1-second pause (p.0.85, paired t-test; Fig. 1D). Furthermore, as
expected from the current-clamp experiments, these large voltage
changes were quite rapid, with onset and offset times of 68657
and 73639 ms respectively for these large voltage swings (Fig. 1E).
Thus, Halo was capable of reliably mediating hyperpolarizations
of large magnitude, with fast onset and offset times at the
beginning and end of light exposure.
Since it is important to evaluate whether a new technology has
unanticipated side effects, such as altering basal cell physiology, or
increasing the propensity for cell death, we conducted several
control experiments. First, we characterized the basal state of
Halo-expressing neurons electrophysiologically when no light was
present. When measured in darkness, there was no difference in
the resting potentials of neurons expressing Halo, and those of
neighboring wild-type neurons (p.0.20, t-test; n=19 Halo-
expressing cells, n=19 wild-type cells; Fig. 2A). Similarly, mem-
brane resistance was not significantly different between the Halo-
expressing cells and the wild-type cells (p.0.70; Fig. 2B). This
result suggests that basal neural activity would be little affected by
the presence of Halo in the absence of light. As an independent
assay for unanticipated effects on cell health, we assayed whether
Halo expression for one week in cultured hippocampal neurons
could lead to apoptosis, using the membrane-impermeant DNA
stain ethidium homodimer-1 to detect any cell membrane break-
down that would accompany apoptotic cell death [36]. We found
no difference in cell death between Halo-expressing and control
wild-type neurons: 16/308 (5.2%) control neurons counted, and
1/22 (4.5%) Halo-expressing neurons counted, were labeled by
ethidium homodimer-1, indicating that Halo was not toxic over
the timecourse of a week of expression (x
2=0.02, p.0.85; Fig. 2C).
Thus, along multiple axes, Halo proved to be well-tolerated by
mammalian neurons, perhaps as expected given its structural
similarity to the well-tolerated photostimulation protein Chan-
nelrhodopsin-2 [18,28,29].
We next probed whether the fast response times of Halo could
support naturalistic sequences of hyperpolarization events, in
response to trains of brief pulses of yellow light. Figure 3A shows
three traces of hyperpolarization events elicited in a single neuron,
resulting from repeatedly playing back a Poisson train (mean inter-
pulse interval, l=100 ms, 59 pulses), of 10 ms-duration yellow
light pulses, to illustratively simulate stochastic inhibitory (e.g.,
GABAergic) synaptic input. Figure 3B shows three such hyper-
polarization traces, taken from different neurons. The variability
of such trains was remarkably low in many regards–across ten
repeated trials in a single cell, across multiple cells (n=5 neurons),
and over time throughout a sustained train of 59 pulses (Fig. 3C,
3D). Notably, we found that for hyperpolarizations elicited by
10 ms-duration light pulses during a l=100 ms Poisson train, the
mean amplitude was 24.56 mV (averaged across trials and
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PLoS ONE | www.plosone.org 2 March 2007 | Issue 3 | e299Figure 1. Millisecond-timescale Halo-mediated neuronal hyperpolarization, elicited by pulses of yellow light. (A) A representative cultured
hippocampal neuron expressing mammalian codon-optimized N. pharaonis halorhodopsin (abbreviated Halo) fused to GFP, under the CaMKII
promoter. Scale bar, 20 mm. (B) Neuronal currents elicited by optical activation of Halo. Left, representative outward currents elicited by two 1-second
pulses of yellow (560627.5 nm) light (,10 mW/mm
2) in a voltage-clamped neuron held at 270mV. Right, population data for n=22 neurons. In this
and subsequent figures, gray bars represent mean 6 standard deviation unless otherwise indicated. Yellow bars in this and subsequent figures
represent the period of yellow light exposure. (C) Kinetic properties of yellow light-elicited, Halo-mediated currents from voltage-clamped neurons.
(i), 15–85% current onset time; (ii), 85–15% offset time. For each measurement, data is presented from neurons held at 270 mV, 230 mV and+10 mV
(left to right). In this panel, gray bars represent mean 6 standard error of the mean (S.E.M.). (D) Neuronal hyperpolarizations elicited by optical
activation of Halo. Left, representative membrane voltage hyperpolarizations elicited by two 1-second pulses of yellow light, in a current-clamped
neuron held at resting membrane potential. Right, population data for n=19 neurons. (E) Kinetic properties of yellow light-elicited, Halo-mediated
hyperpolarizations from current-clamped neurons, including both 15–85% voltage change onset time and 85–15% offset time.
doi:10.1371/journal.pone.0000299.g001
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was only 400 mV (averaged across neurons, Fig 3Ci and Fig. 3Di,
left side). The trial-to-trial jitter of the time the hyperpolarization
took to reach its peak value was also small, 1.27 ms (averaged
across neurons, Fig. 3Cii and Fig. 3Dii, left side). The neuron-to-
neuron variability of amplitude and timing was somewhat larger
than the trial-to-trial variability, with standard deviations of
1.45 mV and 1.78 ms, respectively, but these values nevertheless
demonstrated that precise inhibitory control of a population of
neurons could take place with millivolt and millisecond resolution.
Finally, we quantitatively examined the through-train sustainabil-
ity of light-elicited voltage changes, by comparing the amplitude
mean and amplitude variability, and timing variability, between
the hyperpolarization events elicited by the first five light pulses in
the 59-pulse train, and the last five light pulses in the train
(Figs. 3Di and 3Dii, left side). No difference was seen for any of
these statistics, compared between the events elicited at the
beginning vs. end of the train (p.0.10 for all measures, t-test).
Identical conclusions held for the l=200 ms Poisson train with 46
pulses (Figs. 3Ciii and 3Civ, and Figs. 3Di and 3Dii, right side).
The high temporal and amplitude fidelity of Halo-mediated
hyperpolarizations suggests that Halo may be an ideal tool for
simulating many forms of synaptic inhibition.
We next analyzed the ability of Halo to enable rapidly-inducible
and rapidly-reversible silencing of neural activity. In patch
clamped neurons, we delivered trains of intracellularly-injected
somatic currents (,300 pA, lasting 4 ms each), causing the
neurons to fire 20 action potentials at 5 Hz with a 100% success
rate (Fig. 4A, ‘‘I-injection’’). We then scheduled yellow light pulses
to occur at certain phases within the somatic current-injection
protocol–specifically, during the times when spikes 7 through 11,
and spike 17, would normally be driven (Fig. 4A, ‘‘Light’’). Finally,
we presented the light pulses and the somatic current injections
simultaneously (Fig. 4A, ‘‘I-injection6light’’, three trials shown),
and discovered that strikingly, spiking was blocked precisely during
the periods of yellow light exposure, and at no other times. Most
remarkably, the rapid onset and offset kinetics of Halo allowed the
deletion of even single spikes–specifically, the second yellow light pulse,
timed to silence just spike 17, was able to eliminate spike 17
without affecting neighboring spikes 16 or 18 at all. We repeated
this experiment five times, on each of n=6 neurons (Fig. 4B).
Across all these experiments, the second pulse of yellow light
reduced the probability of firing spike 17 to 3.3%, whereas
neighboring spikes 16 and 18 fired 96.7% of the time; this latter
success probability was not significantly different from the success
rate of the first spike in the train, before any light exposure at all
(x
2=1.02, p.0.30). In total, during periods when the yellow light
was off, somatic current pulses elicited spikes 98.7% of the time,
whereas during periods when the yellow light was on, somatic
current pulses elicited spikes only 1.2% of the time. The temporal
precision of Halo in silencing spikes therefore offers a novel
method of creating ultratransient, precise, and effective inhibition
of activity in genetically-specified neurons.
Halo-mediated currents and hyperpolarizations appeared to
decay slightly during 1-second long pulses of yellow light (Fig. 1B,
D), raising the question of how Halo might perform during longer-
duration neural silencing experiments. We exposed Halo-expres-
sing neurons to continuous yellow light, and found that the
hyperpolarization decayed with a time constant of approximately
16.8610.4 seconds (n=8 neurons; representative trace shown in
Fig. 5Ai). We tested for recovery of Halo function after 15 seconds
of yellow light, with repeated 1-second test pulses of yellow light
delivered every 30 seconds, and found that even after four such
rest periods, the hyperpolarization peak amplitude remained down
by 33% from its original peak amplitude, suggesting that the Halo
protein had entered an inactive state (Fig. 5Ai and Fig. 5B, black
dots). Earlier studies on halorhodopsin from another archaebac-
terium, Halobacterium halobium, found evidence for a similar type of
rundown, due to accumulation of an inactive 13-cis retinal form of
the halorhodopsin molecule, which required seconds to recover to
Figure 2. Safety of Halo in cultured hippocampal neurons. (A) Membrane resting potential of Halo-expressing vs. wild-type neurons (n=19 each).
(B) Membrane resistance of Halo-expressing vs. wild-type neurons. (C) Fraction of Halo-expressing (n=22) vs. wild-type (n=308) cultured neurons
whose nuclei stained positive for the membrane-integrity assessing DNA stain ethidium homodimer-1.
doi:10.1371/journal.pone.0000299.g002
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that brief periods of blue light could facilitate rapid recovery of H.
halobium halorhodopsin to the active form, by assisting in the re-
isomerization of 13-cis retinal to the all-trans form. For Halo, we
found that a brief pulse of moderate-intensity blue light
(,10 mW/mm
2 400 ms-long), delivered through the GFP
excitation filter) could completely restore Halo to its active state
(Fig. 5Aii), recovering the hyperpolarizations elicited by the test
pulses of yellow light to their original amplitude (p.0.05 for each
test pulse, paired t-test; n=8; Fig. 5B, open blue dots). Thus,
Figure 3. Halo-mediated naturalistic trains of inhibitory events. (A) Three voltage traces of a representative current-clamped hippocampal neuron,
exposed to a Poisson train of yellow light pulses. Each light pulse lasts 10 ms, and the Poisson train has a mean inter-pulse interval of l=100 ms. (B)
Voltage traces of three different representative current-clamped neurons exposed to the same Poisson train of light pulses (l=100 ms). (C) Properties
of hyperpolarization events elicited by Poisson trains with inter-pulse interval l=100 ms (i, ii) and l=200 ms (iii, iv), plotted versus onset time of
each light pulse. Plots (i) and (iii) show the peak amplitude of each hyperpolarization event (black symbols), as well as the across-trials standard
deviation of these amplitude values across ten trials (gray symbols). Plots (ii) and (iv) show the latency between the onset time of the light pulse and
the time of the hyperpolarization peak (black symbols), as well as the across-trials standard deviation of these timing values across ten trials (gray
symbols). In this panel, plotted points are across-neuron mean6S.E.M. (n=5 neurons). (D) Comparison of the peak hyperpolarization (i) and the time-
to-peak (ii) data between the beginning (first5) and end (last5) of each Poisson train, for the n=5 neurons described in Fig. 3C. In (i): for each neuron,
the average of the first 5 or last 5 hyperpolarization peaks (black) or the across-trials standard deviation of these amplitude values (gray) was first
computed, then the across-neuron mean6S.E.M. was plotted. In (ii): for each neuron, the average of the first 5 or last 5 times-to-peak (black) or the
across-trials standard deviation of these times-to-peak (gray) were first computed, then the across-neuron mean6S.E.M. was plotted. For (ii), the gray
bars were stacked on top of the black ones for ease of visualization.
doi:10.1371/journal.pone.0000299.g003
Neural Control with Light
PLoS ONE | www.plosone.org 5 March 2007 | Issue 3 | e299Figure 4. Halo-mediated silencing of neuronal spiking. (A) Light-driven spike blockade, demonstrated for a representative hippocampal neuron.
Top (‘‘I-injection’’), neuronal firing of 20 spikes at 5 Hz, induced by pulsed somatic current injection (,300 pA, 4 ms). Middle (‘‘Light’’), membrane
hyperpolarization induced by two periods of yellow light, timed so as to be capable of blocking spikes 7–11 and spike 17, out of the train of 20 spikes.
Bottom (‘‘I-injection6Light’’), yellow light drives Halo to block neuron spiking (note absence of spikes 7–11 and of spike 17), while leaving spikes
elicited during periods of darkness largely intact. (B) Population data (n=6 neurons) for light-driven, Halo-mediated spike blockade, showing high
spike probability during periods of darkness (spikes 1–6, 12–16, and 18–20), and low spike probability during periods of yellow light illumination
(spikes 7–11 and spike 17). Error bars (S.E.M.) are smaller than the points plotted.
doi:10.1371/journal.pone.0000299.g004
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Halo-expressing neurons to yellow light, brief periods of blue light
exposure will facilitate the optimal performance of Halo during
long periods of neural inhibition in vivo.
We recently showed that one member of the type I opsin family,
the light-activated cation channel Channelrhodopsin-2 (ChR2),
could mediate neural excitation in response to pulses of blue light
(,470 nm, delivered through a standard GFP excitation filter)
[18]. Furthermore, the excitation peak of ChR2 is spectrally
separated far enough from Halo that commonly-available
fluorescence excitation filters (e.g., HQ450/50x and HQ590/
556) may be sufficient to enable neural photostimulation and
photoinhibition (illustrated in Fig. 6A). We targeted individual
neurons simultaneously with both Halo and the human codon-
optimized form of ChR2 (with the red fluorophore mCherry [38]
fused to the C-terminus, for ease of visualization), both under
control of the CaMKII promoter (Fig. 6B). mCherry was
visualized with the same Texas red filter used to stimulate Halo
(see [38] for detailed spectral properties). Note that due to spectral
overlap, mCherry visualization (with yellow light) can result in
Halo stimulation, and GFP visualization (with blue light) can result
in ChR2 stimulation, so from a practical standpoint using the
ChR2/Halo system as here configured requires cell identification
and voltage control to occur during distinct experimental stages.
We found that such neurons could respond to rapidly-switched
pulses of yellow and blue light with hyperpolarizations and
depolarizations respectively (Fig. 6C). Poisson trains (mean inter-
Figure 5. Blue light facilitates optimal Halo function. (A) (i)
Timecourse of Halo-mediated hyperpolarizations in a representative
current-clamped hippocampal neuron during 15 seconds of continuous
yellow light, followed by four 1-second test pulses of yellow light (one
every 30 seconds, starting 10 seconds after the end of the first 15-
second period of yellow light). (ii) Timecourse of Halo-mediated
hyperpolarization for the same cell exhibited in (i), but when Halo
function is facilitated by a 400-ms pulse of blue light in between the 15-
second period of yellow light and the first 1-second test pulse. (B)
Population data for blue-light facilitation of Halo recovery (n=8
neurons). Plotted are the hyperpolarizations elicited by the four 1-
second test pulses of yellow light, normalized to the peak hyperpolar-
ization induced by the original 15-second yellow light pulse. Dots
represent mean6S.E.M. Black dots represent experiments when no blue
light pulse was delivered (as in Fig. 5Ai.). Open blue dots represent
experiments when 400 ms of blue light was delivered to facilitate
recovery (as in Fig. 5Aii.).
doi:10.1371/journal.pone.0000299.g005 Figure 6. Bi-directional optical control of voltage with blue and
yellow light pulses. (A) Action spectrum for ChR2 (blue, adapted from
[71]), overlaid with absorption spectrum for N. pharaonis halorhodopsin
(orange, adapted from [32]). Each spectrum is normalized to its own
peak, for ease of comparison. Gray bars denote bandpass windows of
commercially-available Chroma HQ450/506 and HQ590/556 filters,
which may be useful for high-fidelity fast-wavelength switching
between ChR2 photostimulation and Halo photoinhibition. (B) Co-
expression of ChR2-mCherry (left) and Halo-GFP (middle) in a single
representative cell expressing both (right, overlay). Scale bar, 20 mm. (C)
Hyperpolarization and depolarization events elicited in a single
representative neuron, by two interleaved 2.5 Hz trains of yellow and
blue light pulses (50 ms duration), denoted by bars of respective
coloration. (D) Hyperpolarization and depolarization events induced in
a representative neuron by a Poisson train (mean inter-pulse interval
l=100 ms) of alternating pulses of yellow and blue light (10 ms
duration), denoted by appropriate colors.
doi:10.1371/journal.pone.0000299.g006
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light pulses elicited rapidly-alternating hyperpolarizations and
depolarizations in the same neuron (Fig. 6D). The ability to drive
excitation and inhibition in the same neuron, using two different
wavelengths of light, may open up the ability to answer questions
for which no current technology permits resolution.
One prominent example of such a long-standing question is
whether synchrony or precise timing of neural activity has an
important or causal role in neural computation. Such activity has
been observed during, or associated with, various brain functions
such as timing-dependent plasticity, global stimulus feature
processing, visuomotor integration, motor planning, and attention
(e.g., [39–43]), and abnormal patterns of neural synchrony have
been associated with a variety of neurological and psychiatric
disorders [44]. To date, however, no generalized strategy has
permitted the disruption of neural synchrony or precisely-timed
spiking without the confound of altering spike rate. To examine
whether Halo and ChR2 together could enable this kind of
experiment, we generated precisely-timed spike trains by re-
peatedly injecting cultured hippocampal neurons with a single
filtered Gaussian white noise current trace (see Fig. 7Ai, top, for
a fragment thereof; see Methods for details). Such noisy currents
had been previously found to induce reliable spike trains in
current-clamped neurons embedded in cortical brain slices [45].
On some trials, we concurrently illuminated the neuron with the
Poisson train of alternating yellow and blue light pulses shown in
Fig. 6D (see Fig. 7Ai, bottom). We found that when delivered
alone, filtered Gaussian white noise currents indeed induced
reliably-timed spike trains (see Fig. 7Aii, top, for twenty overlaid
traces, and Fig. 7Aiii, top, for corresponding spike rasters). When
Halo and ChR2 were concurrently driven by a Poisson train of
yellow and blue light pulses, the spike timings were different from
those of spikes elicited in darkness, but were still reliable from trial
to trial (see Fig. 7Aii, bottom, and Fig. 7Aiii, bottom, for overlaid
traces and spike rasters respectively). Inspection of spike
histograms (Fig. 7Aiv) clearly shows that relative to the spike train
elicited by current injection in darkness, optically driving Halo and
ChR2 could sometimes abolish previously reliable spikes, create
new spikes, or advance or delay the timing of specific spikes. We
compared mean spike rates for neurons receiving filtered Gaussian
white noise current injection alone vs. with additional illumination,
and found no difference in spike rates for these two conditions
Figure 7. Multichannel optical disruption of precise spike timing, without alteration of spike rate. (A) Optical disruption of spike timing, without
alteration of spike rate, for a representative neuron expressing both ChR2 and Halo. (i), stimulus traces showing subsegments of the somatically
injected filtered Gaussian white noise current used in all these experiments (top), as well as of the Poisson train (mean inter-pulse interval l=100 ms)
of alternating yellow and blue light pulses (bottom). (ii), twenty-trace overlays of voltage responses to the somatically injected white noise current,
either with no light (top, black traces) or with delivery of a Poisson train of yellow and blue light pulses (bottom, green traces). (iii), spike raster plots
for the traces shown in Fig. 7Aii. (iv), spike-timing histograms (bin size: 500 ms) for the rasters shown in Fig. 7Aiii. (B) Spike rates of neurons (n=7)
injected with filtered Gaussian white noise current, either with no light (left) or with concurrent delivery of a Poisson train of yellow and blue light
pulses (right). Plotted is mean6S.E.M. (C) Cross-correlation between spike trains elicited from the same filtered Gaussian white noise current injection,
played twice, when either both current injections were performed in the dark (black curve), or when one of the current injections was performed with
concurrent delivery of a Poisson train of yellow and blue light pulses (green trace). Data is plotted as mean6S.E.M (averaged across n=7 neurons).
See Methods for details.
doi:10.1371/journal.pone.0000299.g007
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intervention preserved spike rate. However, precise spike timing
was altered significantly: cross-correlations of Gaussian current
injections delivered alone vs. delivered with concurrent illumina-
tion resulted in zero-lag cross-correlations that were on average
37% smaller than cross-correlations of pairs of spike traces
resulting from Gaussian current injections alone (p,0.005, see
Methods for details of this analysis). This indicates that precise
spike timing was indeed disrupted by the activation of Halo and
ChR2, even while spike rate was preserved. Thus, Halo and ChR2
are synergistic reagents, together enabling two-color controlled
excitation and inhibition of individual, genetically-specified
neurons. The ChR2/Halo system constitutes an easy-to-use, yet
powerful, optical toolbox for the analysis and engineering of
genetically-specified circuit elements in the brain, and also opens
up the bidirectional optical voltage control of a variety of
electrically excitable cells.
DISCUSSION
We here reveal a genetically-encoded reagent for the safe and
effective silencing of neural activity, in the mammalian codon-
optimized gene for N. pharaonis halorhodopsin (abbreviated Halo).
Even a brief pulse of yellow light could completely silence the
spiking of a Halo-expressing neuron, and yet allow normal spiking
activity within milliseconds after light cessation. Furthermore,
individual neurons could express the yellow light-activated
chloride pump Halo and the blue-light activated cation channel
ChR2, and respond to yellow vs. blue light with oppositely-
directed voltage changes. This ability to bidirectionally control
neural activity allowed us to disrupt precise spike timing of neural
activity without altering spike rate, a long-desired tool for systems
neuroscientists interested in the role of synchronous or precisely
timed neural activity in the brain. The ability to hyperpolarize and
depolarize a neuron at will with multiple colors of light powerfully
extends the optical toolbox accessible to the modern neuroscien-
tist. When compared to the pioneering study on optical
inactivation of neuronal activity, which used rat rhodopsin 4
(RO4) to enable light-driven G-protein-mediated activation of
potassium conductances and inhibition of calcium channels [27],
Halo possesses a number of useful properties, perhaps consistent
with its being a monolithic protein capable of both sensing light
and directly influencing neuronal voltage. The timescales of
induction of and release from voltage inhibition by Halo are about
5 and 90 times faster, respectively, than demonstrated for RO4. In
addition, Halo mediates light-driven hyperpolarizations of ampli-
tude.350% of those mediated by RO4 or other G-protein
mediated methods such as baclofen administration, which may aid
in the observed high performance of Halo in neuronal spike
blockade, a highly nonlinear process.
Even by itself, Halo presents a number of technological
opportunities for the practicing neuroscientist. Although simulat-
ing excitation is possible with multiple tools such as ChR2 and
glutamate uncaging, in which pulses of UV light cause chemical
release of excitatory neurotransmitter [46–48], no tool for optical
inhibition has yet become widespread. Here we show that even
millisecond pulses of light can induce hyperpolarizations of several
millivolts, and therefore may be useful in a variety of contexts for
simulating background or well-timed inhibitory synaptic activity.
Creating fusion proteins in which Halo is targeted to specific
locations where inhibitory synapses uniquely cluster–for example,
the axon initial segment of certain cell types [49,50], or other
locations where GABAergic receptors accumulate [51–53]–may
enhance the use of Halo for the study of the function of not only
specific cell types, but specific classes of inhibitory synapse.
The ability to functionally lesion brain regions, or cell types, in
a rapidly reversible fashion opens up a large class of experiments in
which specific neuron populations must be inactivated for precise,
sub-second durations during a task. As has been shown in multiple
earlier studies, the mammalian brain contains sufficient levels of
all-trans retinal in vivo to enable function of type I opsins such as
ChR2 [28,29], and so Halo will likely immediately find powerful
uses in the intact mammalian brain, and in brain slice
experiments. Laboratories working on classical neural model
organisms such as Drosophila and C. elegans have devised ways of
delivering all-trans-retinal to the nervous systems of such animals
in order to enable ChR2 function [54,55], and these protocols
would therefore also enable the function of Halo in these
invertebrates. Accordingly, we predict that the ability to optically
silence neural activity in multiple kinds of organism using Halo will
transpire in quite short order. In addition, the newly-enabled
ability to drive excitation and inhibition of genetically-targeted
neurons with blue and yellow light will likely be particularly
valuable for probing the role of specific subsets of neurons in
neural computations. For example, the ability to drive a specific set
of neurons, while inhibiting activity in a subgroup of the neurons
that the first set synapses upon, may allow new ways of analyzing
the necessity and sufficiency of neural activity in complex,
distributed neural circuits. In addition, the ability to play back
balanced, yet random, patterns of excitation and inhibition may
open up new horizons into understanding the causal role of precise
spike timing or neural synchrony in brain function and disease, an
area of longstanding yet growing interest.
Optical methods for altering neural circuit function have appeal
in part because they can in principle piggyback off of the large
amount of effort scientists have invested in microscopy technology
development, especially in recent years towards in vivo brain
imaging. For example, the ability to use optical fibers to image
deep neural circuits [56] may enable the ability to stimulate or
inhibit specific neurons within deep brain structures. For creation
of narrowband, high-intensity light, LEDs and solid-state diode
lasers have become progressively inexpensive, bright, and easy-to-
use. Two-photon excitation methods will likely prove valuable for
driving excitatory and inhibitory opsin activity in neurons up to
1 mm deep [57]. Another key aspect of optical methods of neural
control is the speed with which activation and inactivation can
take place, since it is trivial to modulate light intensity at high
speeds, faster than practically all physiologically relevant processes.
Accordingly, in addition to reagents for neural excitation and
inhibition, other light-sensitive reagents may prove useful in the
endeavor to analyze and control neural circuits. One recent
publication revealed how to simulate neurotransmitter receptor
activation in response to light, for example [58]. In addition, a few
recent papers describe reagents that enable signaling pathways to
be driven in response to light, including the creation of the second
messenger cyclic AMP (cAMP) in response to light [59], or optical
control of the beta-adrenergic signaling pathway using a beta-
adrenergic receptor/rhodopsin hybrid protein [60]. Such tools
may be useful for testing the causal role of signaling and gene
expression changes in specific cells in memory circuits and reward
pathways. Nevertheless, non-optical and chemical approaches will
continue to find many uses for reliable, enduring inhibition of
specific brain circuits and cell types–especially when large regions
of deep brain tissue are involved.
From a neuroengineering standpoint, optical prosthetics
capable of inhibiting neural activity may present less-invasive
strategies for treating disorders of neural hyperactivity. Aside from
the very prominent use of pharmacological inhibitors of neural
excitability in treating neurological and psychiatric disorders, few
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ChR2 has already proven to be well-tolerated in intact mamma-
lian neural circuits–up to a year, the longest time yet described in
a publication [29]; if Halo gains a similar track record, it is possible
that Halo-enabled prosthetics may open up new horizons in con-
trolling disorders of excitable cells such as epilepsy [61], depression
[12], neuropathic pain [62], and cardiac hyperexcitability [63,64].
Already the targeting of ChR2 to retinal ganglion cells has been
shown to strikingly restore light-driven responses in the visual
cortex of mice lacking photoreceptors [29]; in principle, a photo-
receptor-lacking retina differentially expressing ChR2 in ‘‘on’’
ganglion cells and Halo in ‘‘off’’ ganglion cells may more accur-
ately convey images from the outside world to the central nervous
system. In the immediate future, the ability to study the effects of
well-timed neuron or circuit inactivation in animal models of
disease may rapidly reveal new principles for selecting neural
circuit targets for treatment of specific disorders. Finally, there are
implications of the use of Halo in biotechnological scenarios, such
as high-throughput drug screening. Several proposals (and even
commercially available systems) exist for using electrical stimula-
tion to depolarize excitable cells, thus facilitating the screening of
depolarization-activated ion channels (e.g., [65]). However, no
comparable method has been proposed for the finding of drugs
that target hyperpolarization-activated channels, such as the
family of channels mediating the hyperpolarization-activated
cation currents I(h) and I(f). Such channels may be useful drug
targets for tackling problems such as absence seizures, bradycar-
dia, and other disorders [66–69]. An all-optical method for
screening for such drugs, which uses light of one frequency to drive
hyperpolarization of a cell line containing Halo and the channel of
interest, and then uses light of another frequency to observe
fluorescence changes of an ion-sensitive chemical or genetically
encoded sensor, could revolutionize the process of finding such
drugs. Thus, Halo not only presents a number of unique features
that will enable effective, and rapidly inducible and reversible,
inhibition to be applied to a number of neural circuit questions,
but will likely open up new horizons in biotechnology as well.
MATERIALS AND METHODS
Plasmid constructs
N. pharaonis halorhodopsin with mammalian-optimized codon
usage (hereafter abbreviated as Halo) was synthesized by Epoch
Biolabs (Sugar Land, Texas, USA). (876 base pairs, DNA
sequence ATGACTGAGACCCTCCCACCCGTGACTGAAA-
GCGCCGTCGCTCTGCAAGCAGAGGTTACCCAGCGGGA-
GCTGTTCGAGTTCGTCCTCAACGACCCCCTCCTGGCT-
TCTAGCCTCTACATCAACATTGCTCTGGCAGGCCTGT-
CTATACTGCTGTTCGTCTTCATGACCAGGGGACTCGA-
TGACCCTAGGGCTAAACTGATTGCAGTGAGCACAATT-
CTGGTTCCCGTGGTCTCTATCGCTTCCTACACTGGG-
CTGGCATCTGGTCTCACAATCAGTGTCCTGGAAATGC-
CAGCTGGCCACTTTGCCGAAGGGAGTTCTGTCATGC-
TGGGAGGCGAAGAGGTCGATGGGGTTGTCACAATGT-
GGGGTCGCTACCTCACCTGGGCTCTCAGTACCCCCA-
TGATCCTGCTGGCACTCGGACTCCTGGCCGGAAGTA-
ACGCCACCAAACTCTTCACTGCTATTACATTCGATAT-
CGCCATGTGCGTGACCGGGCTCGCAGCTGCCCTCAC-
CACCAGCAGCCATCTGATGAGATGGTTTTGGTATGC-
CATCTCTTGTGCCTGCTTTCTGGTGGTGCTGTATAT-
CCTGCTGGTGGAGTGGGCTCAGGATGCCAAGGCTGC-
AGGGACAGCCGACATGTTTAATACACTGAAGCTGCT-
CACTGTGGTGATGTGGCTGGGTTACCCTATCGTTTG-
GGCACTCGGCGTGGAGGGAATCGCAGTTCTGCCTG-
TTGGTGTGACAAGCTGGGGCTACTCCTTCCTGGACA-
TTGTGGCCAAGTATATTTTTGCCTTTCTGCTGCTGA-
ATTATCTGACTTCCAATGAGTCCGTGGTGTCCGGCT-
CCATACTGGACGTGCCATCCGCCAGCGGCACACCTGC-
CGATGACTGA). The Halo-GFP fusion protein sequence was
generated by PCR amplification of the Halo gene with primers
59-GAATTCGCCACCATGACTGAGACCCTCCCACCCGTG
and 39-GGATCCGTCATCGGCAGGTGTGCCGCTGGC and
inserted into the EcoRI and BamHI sites of pEGFP-N3
(Clontech), which has the CMV promoter. The Halo-GFP
fusion protein sequence was then PCR amplified with primers
59-CCGGTGCCACCATGACTGAGACCCTCCCACCCGTG
and 39-GAATTCTTACTTGTACAGCTCGTCCATGCC and
inserted into the lentiviral vector FCK(1.3)GW containing the
CaMKII promoter [35] via AgeI and EcoRI sites, to make
vector FCK-HaloGFP. All constructs were verified by thorough
sequencing. The channelrhodopsin construct used in this paper,
FCK-hCmC, contains the human codon-optimized gene ChR2
(sequence found at [70]) fused to the fluorescent protein
mCherry [38], under the CaMKII promoter [35].
Hippocampal neuron culture and imaging
Sprague-Dawley rats (Charles River) were handled in accordance
with the guidelines of the MIT Committee on Animal Care.
Hippocampal regions CA3-CA1 of postnatal day 0 or day 1 rats
were isolated and treated with trypsin (1 mg/ml) for 12 min.
Digestion was stopped by Hanks solution supplemented with 20%
fetal bovine serum and trypsin inhibitor. Tissue was dissociated
with silicone-coated Pasteur pipettes and centrifuged at 1000 rpm
at 4uC for 10 min. Dissociated neurons were plated on glass
coverslips pre-coated with Matrigel (BD Biosciences) at a rough
density of approximately two hippocampi per 24 coverslips.
Neurons were transfected using a commercially available calcium
phosphate transfection kit (Invitrogen), at 3–5 days in vitro. GFP
fluorescence was used to identify successfully-transfected neurons,
indicating a net transfection efficiency of ,7%. All images and
electrophysiological recordings were made on 9–15 day -in-vitro
neurons (approximately 6–10 days after transfection). Confocal
images of transfected neurons were taken with a Zeiss LSM 510
confocal microscope. Cell death count was carried out on living
cultures, seven days after transfection, by adding 4 mM ethidium
homodimer-1 (Invitrogen) to the culture medium for 10 mins at
37uC, then washing the cells with Tyrode’s solution (see below).
GFP-positive and negative neurons were counted for positive and
negative ethidium fluorescence, in three regions on each of five
coverslips, for this viability assay.
Electrophysiology and optical methods
Whole cell patch clamp recording was made on 9–15 day-in-vitro
neurons using a Multiclamp 700B amplifier, connected to
a Digidata 1440 digitizer (Molecular Devices) attached to a PC
running pClamp 10. During recording, neurons were bathed in
Tyrode’s solution containing (in mM) 150 NaCl, 2.4 KCl, 2 CaCl,
2 MgCl, 10 HEPES, 10 Glucose, 10 mM NBQX, 10 mM gabazine
and 50mM D-APV. Borosilicate glass (Warner) pipettes were filled
with a solution containing (in mM) 130 K-Gluconate, 7 KCl, 2
NaCl, 1 MgCl2, 0.4 EGTA, 10 HEPES, 2 ATP-Mg, 0.3 GTP-
Tris and 20 sucrose. Pipette resistance was ,5M V and the access
resistance was 10–25 MV, which was monitored throughout the
voltage-clamp recording. Resting membrane potential was 252 to
270 mV in current-clamp recording.
Photocurrents were first measured with pairs of 1-second long
light pulses, separated by periods of darkness lasting 1 second,
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and+10 mV to assay the properties of Halo. Light-induced
membrane hyperpolarizations were induced by 1 s duration light
pulses, separated by periods of 1 s in the dark, in neurons current-
clamped at resting membrane potential. Light pulse trains were
synthesized by custom software written in MATLAB (Mathworks),
then played to the DG-4 light source through a digital-to-analog
converter on the Digidata 1440. For the spike-blockade exper-
iment, spikes were first induced via somatic current injection
through the patch pipette; neurons easily fired repeated action
potentials with ,100% probability, in response to ,300 pA
current injections (4 ms duration).
A DG-4 optical switch with 300-W xenon lamp (Sutter
Instruments) was used to deliver all light pulses, for Halo or
ChR2 activation. A Texas Red filter set (Chroma, excitation
bandpass 560627.5 nm, dichroic 595LP) was used to deliver
yellow light to activate Halo. The same dichroic mirror was also
used to deliver blue light, but with a standard GFP excitation filter
(bandpass 480620 nm) in the DG-4, to allow ChR2 excitation.
Note that the 595LP dichroic mirror only reflects 35% of 460–
500 nm light through the objective; custom-coated dichroics that
reflect light all the way into the ultraviolet (as are available from
companies such as Chroma) would be optimal.
Precise timing-disruption experiments were conducted by using
stimuli modeled after those in [45]. Briefly, we current-clamped
cultured hippocampal neurons with a 4-second long Gaussian
white noise current (mean 40–100 pA, standard deviation 20–
70 pA) low-pass filtered with a first-order Butterworth filter with
cutoff frequency of 100 Hz. Concurrently, neurons were, on half
the trials, also exposed to a mean inter-pulse interval l=100 ms
Poisson train of alternating yellow and blue light pulses.
Identically-shaped, filtered Gaussian white noise currents, and
the same optical Poisson train, were used for all trials on all
neurons to facilitate comparison. For each neuron, we acquired
between 10 and 20 traces in each of the dark and illuminated
conditions, taking equal numbers in each condition to facilitate
data analysis.
Data analysis
Amplitude and timing data were analyzed using Clampfit 10
(Molecular Devices) and custom analysis scripts written in
MATLAB. Onset times and offset times of currents and voltages
were measured as the duration the electrical signal takes to
transition between 15% and 85% of peak value, with respect to
baseline. Statistics analysis was done with Prism (GraphPad
Software Inc.) and Statview (SAS Institute). Figure 6A was created
using DigitizeIt software applied to the cited source materials
(ShareIt Inc., Germany).
Precise spike timing experiments were analyzed using Clampfit
10 and MATLAB. Specifically, the rasters in Fig. 7Aiii were made
by thresholding voltage traces at 210 mV in Clampfit, which
cleanly isolated spikes from non-spike membrane fluctuations. The
spike time histogram in Fig. 7Aiv has a bin size of 500 ms. The
cross-correlation analysis (Fig. 7C) was performed by first assigning
each spike a 1 ms long presence (1 ms of ones) centered around
the spike peak, and assigning the rest of the trace zeros. Then, we
computed cross-correlations for each neuron between spike trains
elicited from the same filtered Gaussian white noise current
injection, played twice, when either both current injections were
performed in the dark (black trace in Fig. 7C), or when one of the
current injections was performed while a Poisson train of yellow
and blue light pulses was concurrently delivered (green trace in
Fig. 7C). For each neuron, cross-correlations were first computed
between all possible pairs within a pairing condition (i.e., dark vs.
dark, and dark vs. light). Individual traces were never cross-
correlated with themselves, for obvious reasons. Then, for each of
the two pairing conditions, the cross-correlation curves were
averaged across all pairs in the pairing condition. Finally, for each
neuron, each of these two averaged curves was then normalized to
the maximum value taken by either averaged curve, to facilitate
comparison of the effect of optical modulation on precise spike
timing across different neurons.
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